Novo Integrated Sciences, Inc. Accounts Receivable, before Allowance for Credit Loss, Current
Novo Integrated Sciences, Inc. had Accounts Receivable, before Allowance for Credit Loss, Current of $3.19 million as of 2024-08-31, per its 10-K filed 2024-12-18.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableGrossCurrent · last filed 2024-12-18
- 2024-08-31: Accounts Receivable, before Allowance for Credit Loss, Current $3.19M.
- 2024-05-31: Accounts Receivable, before Allowance for Credit Loss, Current $3.09M.
- 2024-02-29: Accounts Receivable, before Allowance for Credit Loss, Current $3.00M.
- 2023-11-30: Accounts Receivable, before Allowance for Credit Loss, Current $3.49M.
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2024-08-31 | $3.19M 10-K · filed 2024-12-18 |
| 2024-05-31 | $3.09M 10-Q · filed 2024-07-19 |
| 2024-02-29 | $3.00M 10-Q · filed 2024-04-15 |
| 2023-11-30 | $3.49M 10-Q · filed 2024-01-22 |
| 2023-08-31 | $2.33M 10-K · filed 2024-12-18 |
| 2023-05-31 | $2.42M 10-Q · filed 2023-07-17 |
| 2023-02-28 | $1.86M 10-Q · filed 2023-05-26 |
| 2022-11-30 | $1.92M 10-Q · filed 2023-05-24 |
| 2022-08-31 | $2.01M 10-K · filed 2023-12-14 |
| 2022-05-31 | $5.87M 10-Q · filed 2022-07-14 |
| 2022-02-28 | $2.31M 10-Q · filed 2022-04-13 |
| 2021-11-30 | $2.77M 10-Q · filed 2022-01-18 |
| 2021-08-31 | $2.57M 10-K · filed 2023-04-03 |
| 2021-05-31 | $1.98M 10-Q · filed 2021-07-14 |
| 2021-02-28 | $1.94M 10-Q · filed 2021-04-14 |
| 2020-11-30 | $1.98M 10-Q · filed 2021-01-13 |
| 2020-08-31 | $2.25M 10-K · filed 2021-12-14 |
| 2020-05-31 | $1.59M 10-Q · filed 2020-07-14 |
| 2020-02-29 | $1.96M 10-Q · filed 2020-04-20 |
| 2019-11-30 | $2.12M 10-Q · filed 2020-01-13 |
| 2019-08-31 | $1.94M 10-K · filed 2020-12-09 |
| 2019-05-31 | $1.86M 10-Q · filed 2019-07-11 |
| 2019-02-28 | $1.85M 10-Q · filed 2019-04-11 |
| 2018-11-30 | $1.86M 10-Q · filed 2019-01-11 |
| 2018-08-31 | $1.80M 10-K · filed 2019-11-20 |
| 2017-08-31 | $1.64M 10-K · filed 2018-11-06 |